Alzamend Neuro
ALZN
11 hedge funds and large institutions have $351K invested in Alzamend Neuro in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
5,429% more capital invested
Capital invested by funds: $6.36K → $351K (+$345K)
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
57% more funds holding
Funds holding: 7 → 11 (+4)
4.43% more ownership
Funds ownership: 0.27% → 4.7% (+4.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$237K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$53.4K |
| 4 |
CA
Clearstead Advisors
Cleveland,
Ohio
|
+$26K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$10 |
| 2 |
AWM
Activest Wealth Management
Aventure,
Florida
|
-$5 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DS
1
DRW Securities
Chicago,
Illinois
| $217K | +$237K | +91,245 | New |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $51.5K | +$56.1K | +21,620 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $49K | +$53.4K | +20,578 | New |
|
|
CA
4
Clearstead Advisors
Cleveland,
Ohio
| $23.8K | +$26K | +10,000 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $4.94K | +$3.05K | +1,173 | +130% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $3.82K | +$2.1K | +809 | +102% |
|
|
7
BlackRock
New York
| $1.04K | -$10 | -4 | -0.9% |
|
8
Bank of America
Charlotte,
North Carolina
| $88 | +$47 | +18 | +95% |
|
|
SS
9
SBI Securities
Tokyo,
Japan
| $52 | – | – | – |
|
|
HIA
10
Harbor Investment Advisory
Lutherville,
Maryland
| $2 | – | – | – |
|
11
Citigroup
New York
| $2 | +$3 | +1 | New |
|
|
AWM
12
Activest Wealth Management
Aventure,
Florida
| – | -$5 | -2 | Closed |
|
ALZN Hedge Fund Activity: Q3 2025 in Review
11 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Alzamend Neuro (ALZN) for Q3 2025, worth a combined $351K — up 5,429% from $6.36K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ALZN positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $237K. The largest seller was BlackRock, cutting an estimated $10.
- 11 institutional investors held Alzamend Neuro (ALZN) as of Q3 2025, up from 7 in Q2 2025.
- Funds reported $351K of Alzamend Neuro stock for Q3 2025, up 5,429% quarter-over-quarter.
- 5 funds opened new Alzamend Neuro positions in Q3 2025 and 1 closed out, a net change of +4 holders.
- The largest Alzamend Neuro buyer in Q3 2025 was DRW Securities, an estimated $237K added.
- The largest Alzamend Neuro seller in Q3 2025 was BlackRock, an estimated $10 sold.
Based on aggregated 13F filings for Q3 2025.